Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
- 14 December 2011
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 133 (3), 334-350
- https://doi.org/10.1016/j.pharmthera.2011.11.010
Abstract
No abstract availableKeywords
This publication has 207 references indexed in Scilit:
- The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapyRadiotherapy and Oncology, 2011
- Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaksDNA Repair, 2010
- DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cellsFree Radical Biology & Medicine, 2010
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastomaJournal of Neuro-Oncology, 2010
- Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing RadiationInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Role of oxidatively induced DNA lesions in human pathogenesisMutation Research, 2010
- Highly Transcribed RNA Polymerase II Genes Are Impediments to Replication Fork Progression in Saccharomyces cerevisiaeMolecular Cell, 2009
- DNA interstrand crosslink repair in mammalian cellsJournal of Cellular Physiology, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Immunofluorescence imaging of DNA damage response proteins: Optimizing protocols for super-resolution microscopyMethods, 2009